News | Focused Ultrasound Therapy | May 12, 2022

Dr. Craig Rogers said the procedure spares surrounding healthy tissue, allows for quicker recovery

Craig Rogers, M.D., performed a robotic high intensity ultrasound case for Charles Rashid, 64, on April 8, 2022. Image courtesy of Henry Ford Health

Craig Rogers, M.D., performed a robotic high intensity ultrasound case for Charles Rashid, 64, on April 8, 2022. Image courtesy of Henry Ford Health


May 12, 2022 — Henry Ford Health is the first in Michigan to offer Robotic High Intensity Focused Ultrasound (HIFU) for the treatment of localized prostate cancer. This non-surgical treatment option spares surrounding healthy tissue, while allowing for a quicker treatment time and recovery for the patient.

“This is a radiation-free procedure that uses high frequency ultrasound waves to treat localized prostate cancer,” said Craig Rogers, M.D., Chair of the Vattikuti Urology Institute at Henry Ford Health. “These sound waves heat up and burn the diseased area of the prostate while sparing other parts of the gland, which can reduce the risk of side effects commonly associated with treatment for prostate cancer, including impotence or urinary incontinence."

Charles Rashid, 64, underwent the procedure performed by Dr. Rogers at Henry Ford Medical Center – Fairlane on April 8. Rashid, a resident of St. Clair Shores, says the procedure was quick and easier than he expected.

“It was unbelievable,” Rashid said. “I was with Dr. Rogers at the Fairlane medical center by 7 a.m., and already back at home by 11 a.m. I was surprised to know that I could be treated without having surgery. After discussing my options with Dr. Rogers, I felt like this was the right choice for me. I’m grateful for the care Dr. Rogers and his team provided, and I can’t say enough about how easy it was.”

Rashid first learned he may have prostate cancer through a routine prostate-specific antigen (PSA) screening ordered by his general practitioner, who referred him to a urology specialist when the results showed an elevated PSA level. When Rashid came to Henry Ford, Dr. Rogers performed a prostate MRI showing a spot suspicious for cancer on one side of the prostate. A targeted biopsy confirmed this abnormal spot to be prostate cancer of an intermediate grade.

The Focal One Robotic HIFU system that Rashid was treated with fuses ultrasound images with images imported from MRIs and biopsy data, allowing the doctor to view 3D images on a monitor and focus the ultrasound waves with greater precision to destroy the specific area of cancerous tissue. As a result, the healthy prostate tissue around the diseased portion is generally unaffected during treatment.

While this procedure may not be appropriate for all patients diagnosed with localized prostate cancer, it is a viable option for those who are not interested in active surveillance and those seeking to avoid treating the entire prostate, such as prostatectomy surgery or radiation. This treatment option offers a middle ground approach to help patients maintain their quality of life.

For more information: www.henryford.com/ProstateCancer

Related prostate cancer content:

SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

PSMA PET Validates EAU Classification System to Determine Risk of Prostate Cancer Recurrence

VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare

FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer

PSMA-Targeted Radiotracer Pinpoints Metastatic Prostate Cancer Across Anatomic Regions

Metastatic Prostate Cancer on the Rise Since Decrease in Cancer Screenings

Rational Surgical Solutions’ mCRPC Master Now Offered as Free Download

A Look Ahead in Targeted Radionuclide Therapy


Related Content

News | Artificial Intelligence

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...

Time February 26, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

February 13, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...

Time February 13, 2024
arrow
News | Information Technology

February 2, 2024 — FUJIFILM Sonosite Inc., a leader in point-of-care ultrasound (POCUS) solutions, announced the launch ...

Time February 02, 2024
arrow
News | Artificial Intelligence

January 25, 2024 — Digital pathology has both sped up and increased the accuracy of cancer diagnosis over the past 10 ...

Time January 25, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
Feature | Artificial Intelligence

Coherent Market Insights has recently published a report, titled, Artificial Intelligence in Oncology Market, By ...

Time January 12, 2024
arrow
Videos | Radiation Oncology

In Part 2 of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory board ...

Time January 09, 2024
arrow
Subscribe Now